A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma

The treatment of cancer is one of the most important pharmacotherapeutic challenges. To this end, chemotherapy has for some time been complemented by targeted therapies against specific structures. PDA-66, a structural analogue of the inhibitor of serine–threonine kinase glycogen synthase kinase 3β...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Rico, Seiler, Elisabeth R. D., Sender, Sina, Pews-Davtyan, Anahit, Murua Escobar, Hugo, Zechner, Dietmar, Beller, Matthias, Junghanß, Christian, Hinz, Burkhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840185/
https://www.ncbi.nlm.nih.gov/pubmed/35164239
http://dx.doi.org/10.3390/molecules27030974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840185/
https://www.ncbi.nlm.nih.gov/pubmed/35164239
http://dx.doi.org/10.3390/molecules27030974

Ejemplares similares